Heat shock protein 27 modification is increased in the human diabetic failing heart

Hormone and Metabolic Research

Volumn 41, Issue 8, 2009, Pages 594-599

  Gawlowski, T ^a   Stratmann, B ^a   Stork, I ^a   Engelbrecht, B ^a   Brodehl, A ^a   Niehaus, K ^b   Korfer R ^a   Tschoepe, D ^a   Milting, H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

Argpyrimidine; Diabetes mellitus; Heart failure; Hsp27; Methylglyoxal

Indexed keywords

ARGININE; GLUCOSE; HEAT SHOCK PROTEIN 27; METHYLGLYOXAL; PYRIMIDINE DERIVATIVE; ARGPYRIMIDINE; DRUG DERIVATIVE; ORNITHINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL GROWTH; CONTROLLED STUDY; CYTOSKELETON; DIABETES MELLITUS; EMBRYO; FEMALE; HEART; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; MALE; NONHUMAN; ORGAN DONOR; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RAT; SAMPLE; SCREENING; AGED; ANIMAL; CELL LINE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHOSPHORYLATION;

RATTUS;

ADULT; AGED; ANIMALS; CARDIOMYOPATHIES; CELL LINE; DIABETES COMPLICATIONS; FEMALE; HEART; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; ORNITHINE; PHOSPHORYLATION; PYRIMIDINES; PYRUVALDEHYDE; RATS;

EID: 70349581637     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1216374     Document Type: Article

References (36)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 813-820
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 339 229-234
3. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006 98 596-605
4. Bucala R, Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 1992 23 1-34
5. Bunn HF, Higgins PJ. Reaction of monosaccharides with proteins: possible evolutionary significance. Science 1981 213 222-224
6. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988 318 1315-1321
7. Cooper ME. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. Am J Hypertens 2004 17 31S-38S
8. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 1992 41 1286-1292
9. Bidasee KR, Zhang Y, Shao CH, Wang M, Patel KP, Dincer UD, Besch HR Jr. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 2004 53 463-473
10. Lee AG, East JM. What the structure of a calcium pump tells us about its mechanism. Biochem J 2001 356 665-683
11. Sweadner KJ, Donnet C. Structural similarities of Na, K-ATPase and SERCA, the Ca(2+)-ATPase of the sarcoplasmic reticulum. Biochem J 2001 356 685-704
12. Berlanga J, Cibrian D, Guillen I, Freyre F, Alba JS, Lopez-Saura P, Merino N, Aldama A, Quintela AM, Triana ME, Montequin JF, Ajamieh H, Urquiza D, Ahmed N, Thornalley PJ. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci (Lond) 2005 109 83-95
13. Lapolla A, Flamini R, Vedova A, Senesi A, Reitano R, Fedele D, Basso E, Seraglia R, Traldi P. Glyoxal and Methylglyoxal Levels in Diabetic Patients: Quantitative Determination by a New GC/MS Method. Clin Chem Lab Med 2003 41 1166-1173
14. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998 101 1142-1147
15. Randell EW, Vasdev S, Gill V. Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography. J Pharmacol Toxicol Methods 2005 51 153-157
16. Ahmed N, Thornalley PJ. Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo. Ann N Y Acad Sci 2005 1043 260-266
17. Padival AK, Crabb JW, Nagaraj RH. Methylglyoxal modifies heat shock protein 27 in glomerular mesangial cells. FEBS Lett 2003 551 113-118
18. Sakamoto H, Mashima T, Yamamoto K, Tsuruo T. Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification. J Biol Chem 2002 277 45770-45775
19. Schalkwijk CG, van Bezu J, van der Schors RC, Uchida K, Stehouwer CD, van Hinsbergh VW. Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells. FEBS Lett 2006 580 1565-1570
20. van Heijst JW, Niessen HW, Musters RJ, van Hinsbergh VW, Hoekman K, Schalkwijk CG. Argpyrimidine-modified Heat shock protein 27 in human non-small cell lung cancer: a possible mechanism for evasion of apoptosis. Cancer Lett 2006 241 309-319
21. Pichon S, Bryckaert M, Berrou E. Control of actin dynamics by p38 MAP kinase Hsp27 distribution in the lamellipodium of smooth muscle cells. J Cell Sci 2004 117 2569-2577
22. Ibitayo AI, Sladick J, Tuteja S, Louis-Jacques O, Yamada H, Groblewski G, Welsh M, Bitar KN. HSP27 in signal transduction and association with contractile proteins in smooth muscle cells. Am J Physiol 1999 277 G445-G454
23. Milting H, Scholz C, Arusoglu L, Freitag M, Cebulla R, Jaquet K, Korfer R, D VL, Kassner A, Brodde OE, Kogler H, El Banayosy A, Pieske B. Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. J Mol Cell Cardiol 2006 41 441-450
24. Milting H, Kassner A, Arusoglu L, Meyer HE, Morshuis M, Brendel R, Klauke B, El Banayosy A, Korfer R. Influence of ACE-inhibition and mechanical unloading on the regulation of extracellular matrix proteins in the myocardium of heart transplantation candidates bridged by ventricular assist devices. Eur J Heart Fail 2006 8 278-283
25. Oya T, Hattori N, Mizuno Y, Miyata S, Maeda S, Osawa T, Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 1999 274 18492-18502
26. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991 68 85-89
27. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 321 405-412
28. Ren J, Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 1997 272 H148-H158
29. Huot J, Houle F, Spitz DR, Landry J. HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 1996 56 273-279
30. Kuethe F, Sigusch HH, Bornstein SR, Hilbig K, Kamvissi V, Figulla HR. Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? Horm Metab Res 2007 39 672-676
31. Oya-Ito T, Liu BF, Nagaraj RH. Effect of methylglyoxal modification and phosphorylation on the chaperone and anti-apoptotic properties of heat shock protein 27. J Cell Biochem 2006 99 279-291
32. Desai KM, Wu L. Free radical generation by methylglyoxal in tissues. Drug Metabol Drug Interact 2008 23 151-173
33. Pleissner KP, Soding P, Sander S, Oswald H, Neuss M, Regitz-Zagrosek V, Fleck E. Dilated cardiomyopathy-associated proteins and their presentation in a WWW-accessible two-dimensional gel protein database. Electrophoresis 1997 18 802-808
34. Chowdhry MF, Vohra HA, Galinanes M. Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: role of caspases and poly-adenosine diphosphate-ribose polymerase. J Thorac Cardiovasc Surg 2007 134 124-131 131 e121e123
35. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. Myocardial cell death in human diabetes. Circ Res 2000 87 1123-1132
36. Shimoni Y, Rattner JB. Type 1 diabetes leads to cytoskeleton changes that are reflected in insulin action on rat cardiac K(+) currents. Am J Physiol Endocrinol Metab 2001 281 E575-E585